SGHC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now for an impatient buyer. Despite strong Q3 growth and a bullish options skew, price action is decisively bearish (break below key pivot/support with momentum deteriorating) and the short-term pattern odds provided also point to further downside. This setup favors waiting for a clear reversal reclaiming ~9.42–9.83 rather than buying immediately at 9.36.
Trend is bearish and accelerating down: SMA_200 > SMA_20 > SMA_5 confirms a sustained downtrend. MACD histogram is negative (-0.00845) and expanding lower, signaling strengthening downside momentum. RSI(6) at ~27.5 indicates near-oversold conditions (bounce risk exists), but oversold alone is not a buy trigger in a downtrend. Price (9.36) is below the pivot (9.833) and below S1 (9.415), putting the next key downside level near S2 (9.157). Near-term resistance is 9.83 (pivot) then ~10.25 (R1); a reclaim of 9.42–9.83 would be the first sign sellers are losing control. Probabilistic pattern read supplied is negative: ~60% chance of further declines over 1D/1W/1M.
Intellectia Proprietary Trading Signals
growth: revenue +25.73% YoY to ~$557M; net income +860% YoY to ~$96M; EPS +850% YoY to $0.19 (suggesting operating leverage). Analyst coverage remains Buy with a still-high target vs price (Benchmark Buy; PT cut to $17). Options market shows aggressive call interest/volume, which can help fuel sharp rebounds if price stabilizes near support.
Clear downside trend with worsening momentum (bearish moving averages + negative/expanding MACD) and price trading below key pivot/support (below 9.415). Short-horizon pattern outlook provided implies continued weakness (next-day/week/month negative expectations). UK Autumn Statement iGaming/remote betting tax increases are an overhang; management estimates ~6% of 2026 AEBITDA impact and an incremental duty burden estimate around ~$40M before mitigation (even if mitigation capacity is substantial). No fresh news catalysts in the last week to reverse sentiment.
2025/Q3 results show strong acceleration: revenue rose to ~$557M (+25.73% YoY), net income to ~$96M (+860% YoY), and EPS to $0.19 (+850% YoY). This indicates robust top-line growth with a sharp improvement in profitability versus the prior year, supporting the longer-term fundamental story even though the stock’s near-term tape is weak.
Recent analyst action: Benchmark (Mike Hickey) maintained a Buy but lowered the price target to $17 from $18 (2025-11-28) due to UK tax increases impacting iGaming/remote betting. Wall Street-style pros: still-rated Buy with large implied upside from 9.36 to 17, and belief the company can mitigate much of the tax impact. Cons: target cut reflects real regulatory/tax headwinds and near-term earnings pressure risk; the market is currently pricing in caution despite strong Q3 prints. Politician/congress activity: no recent congress trading data available; hedge fund and insider trends are neutral.
